In this study, we demonstrated that the expression of CXCL12 in ESCC is an independent risk factor of recurrence after surgery through immunohistochemistry and we showed that CXCL12 promotes ESCC proliferation. The gene discussed is CXCL12; the disease is esophageal squamous cell carcinoma.